comprehensive -WSS

comprehensive

author：comprehensive 2025-09-30 17:45:19 - browse：353

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Caribou posts encouraging results on off

hotspot

focus

WSS

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

More doctors should go into startup world

Judge denies Trump's request for new trial in E. Jean Carroll case

Biotech incubator Curie.Bio graduates its first startup

Will General Catalyst be the first of many hospital takeovers?

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

focus

comprehensive

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

STAT Executive Editor Rick Berke on STAT's 8th birthday

The cancer drug shortage isn’t new — and neither are the solutions

STAT Executive Editor Rick Berke on STAT's 8th birthday

BioMarin wins approval for gene therapy to treat hemophilia A

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

DIEP, the 'gold standard' of breast reconstruction, is under threat

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Affirmative action in medical school literally saved lives

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

entertainment

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Sanofi CEO defends move to abandon profit guidance, boost research

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Excited delirium, Elijah McClain, and emergency physicians

FDA approves potent Eli Lilly obesity drug, Zepbound

More doctors should go into startup world

focus

hotspot

focus

focus